Loading
Latest filing published 06 Jul 2026 for LSL Pharma Group Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alain Dugal is a declared insider of LSL Pharma Group Inc., with filings sourced from SEDI. The record holds 3 filings, for trades running from 28 May 2026 to 3 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 July 2026, the filings show an option exercise in LSL Pharma Group Inc. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations